{"id":"regular-human-insulin-or-insulin-aspart","safety":{"commonSideEffects":[{"rate":"variable, dose-dependent","effect":"Hypoglycemia"},{"rate":"common","effect":"Weight gain"},{"rate":"5-10","effect":"Injection site reactions"},{"rate":"rare to uncommon","effect":"Lipodystrophy"}]},"_chembl":{"chemblId":"CHEMBL1201496","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Both are insulin formulations that mimic the body's natural insulin hormone. Regular human insulin is a short-acting formulation, while insulin aspart is a rapid-acting analog with a faster onset and shorter duration. They work by binding to insulin receptors on muscle, fat, and liver cells, facilitating glucose transport into cells and promoting anabolic metabolism.","oneSentence":"Regular human insulin and insulin aspart bind to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:04:27.494Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus (when oral agents are insufficient)"},{"name":"Gestational diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT04012138","phase":"PHASE4","title":"Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2019-12-20","conditions":"Hyperkalemia","enrollment":525},{"nctId":"NCT04031599","phase":"NA","title":"Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2020-07-10","conditions":"Type 1 Diabetes","enrollment":30},{"nctId":"NCT04834362","phase":"PHASE4","title":"Insulin for Hyperglycemia in Stroke Trial","status":"COMPLETED","sponsor":"National Institute of Neurosciences and Hospital, Dhaka","startDate":"2021-04-05","conditions":"Hyperglycemia, Stroke, Acute","enrollment":452},{"nctId":"NCT03495908","phase":"NA","title":"Regular Insulin vs Rapid Insulin Delivered by V-Go","status":"COMPLETED","sponsor":"East Coast Institute for Research","startDate":"2018-04-09","conditions":"Type 2 Diabetes, Type 2 Diabetes Mellitus","enrollment":136},{"nctId":"NCT02814123","phase":"PHASE2","title":"Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes","status":"COMPLETED","sponsor":"McGill University","startDate":"2017-01-13","conditions":"Diabetes Mellitus, Type 1","enrollment":28},{"nctId":"NCT02556918","phase":"PHASE4","title":"Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2016-01","conditions":"Hyperglycemia","enrollment":202},{"nctId":"NCT02269735","phase":"PHASE1","title":"A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2014-11-26","conditions":"Type 1 Diabetes Mellitus","enrollment":74},{"nctId":"NCT02443402","phase":"PHASE4","title":"Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2016-01","conditions":"Coronary Artery Disease","enrollment":68},{"nctId":"NCT02490098","phase":"PHASE2","title":"Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes","status":"WITHDRAWN","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2018-01","conditions":"Type 1 Diabetes","enrollment":""},{"nctId":"NCT00574405","phase":"NA","title":"Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy","status":"COMPLETED","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2005-04","conditions":"Diabetes Mellitus","enrollment":24},{"nctId":"NCT02798250","phase":"PHASE2","title":"Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2016-06","conditions":"Type 1 Diabetes","enrollment":11},{"nctId":"NCT00071448","phase":"PHASE3","title":"Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-06","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":378},{"nctId":"NCT00000620","phase":"PHASE3","title":"Action to Control Cardiovascular Risk in Diabetes (ACCORD)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1999-09","conditions":"Atherosclerosis, Cardiovascular Diseases, Hypercholesterolemia","enrollment":10251},{"nctId":"NCT02222623","phase":"NA","title":"The Inova Type 2 Diabetes Mellitus Study","status":"WITHDRAWN","sponsor":"Inova Health Care Services","startDate":"2015-04","conditions":"Diabetes, Type 2","enrollment":""},{"nctId":"NCT01029444","phase":"PHASE3","title":"Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes","status":"TERMINATED","sponsor":"Florida Atlantic University","startDate":"2007-03","conditions":"Diabetes Mellitus","enrollment":300},{"nctId":"NCT01648218","phase":"PHASE4","title":"Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia","status":"TERMINATED","sponsor":"Vancouver General Hospital","startDate":"2012-08","conditions":"Post-Transplant Glucocorticoid Induced Diabetes","enrollment":5},{"nctId":"NCT02416765","phase":"PHASE2","title":"Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2015-05","conditions":"Type 1 Diabetes","enrollment":15},{"nctId":"NCT00663624","phase":"PHASE4","title":"Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care","status":"WITHDRAWN","sponsor":"Emory University","startDate":"","conditions":"Diabetes","enrollment":""},{"nctId":"NCT00174668","phase":"PHASE3","title":"Insulin Glulisine in Diabetes Mellitus, Type 2","status":"COMPLETED","sponsor":"Sanofi","startDate":"2004-11","conditions":"Diabetes Mellitus, Type 2","enrollment":311}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3763,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Humulin R","Novolin R","Novolog","NovoRapid"],"phase":"marketed","status":"active","brandName":"Regular human insulin or Insulin Aspart","genericName":"Regular human insulin or Insulin Aspart","companyName":"Vancouver General Hospital","companyId":"vancouver-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Regular human insulin and insulin aspart bind to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus (when oral agents are insufficient), Gestational diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}